MPT: NOAC Helps Stem Consequences of Cardiac Damage After Surgery

ACC Conference Reporter

ACC.18 | ORLANDO, FL — Dabigatran (Pradaxa) reduces risk of major vascular events for patients who have a heart attack or troponin elevation after noncardiac surgery, the MANAGE trial showed. Read More >>>



Keywords: ACC18, ACC Annual Scientific Session


< Back to Listings